Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The price of Chimerix Inc (NASDAQ: CMRX) closed at $3.80 in the last session, down -3.55% from day before closing price of $3.94. In other words, the price has decreased by -$3.55 from its previous closing price. On the day, 1.56 million shares were traded. CMRX stock price reached its highest trading level at $3.99 during the session, while it also had its lowest trading level at $3.78.
Ratios:
We take a closer look at CMRX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 6.33 and its Current Ratio is at 6.33. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Robert W. Baird on May 23, 2023, initiated with a Outperform rating and assigned the stock a target price of $7.
On September 07, 2022, CapitalOne started tracking the stock assigning a Overweight rating and target price of $7.
On April 29, 2021, Maxim Group started tracking the stock assigning a Buy rating and target price of $20.Maxim Group initiated its Buy rating on April 29, 2021, with a $20 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 30 ’25 when Jakeman David sold 2,800 shares for $4.10 per share. The transaction valued at 11,470 led to the insider holds 149,287 shares of the business.
LaSpaluto Michelle sold 1,015 shares of CMRX for $4,172 on Jan 30 ’25. The CHIEF FINANCIAL OFFICER now owns 175,237 shares after completing the transaction at $4.11 per share. On Jan 30 ’25, another insider, Andriole Michael T., who serves as the PRESIDENT AND CEO of the company, sold 2,350 shares for $4.10 each. As a result, the insider received 9,636 and left with 616,973 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CMRX now has a Market Capitalization of 341898912 and an Enterprise Value of 206171008. For the stock, the TTM Price-to-Sale (P/S) ratio is 2135.99 while its Price-to-Book (P/B) ratio in mrq is 2.52. Its current Enterprise Value per Revenue stands at 1296.673 whereas that against EBITDA is -2.223.
Stock Price History:
The Beta on a monthly basis for CMRX is 0.34, which has changed by 3.236559 over the last 52 weeks, in comparison to a change of 0.21926713 over the same period for the S&P500. Over the past 52 weeks, CMRX has reached a high of $4.22, while it has fallen to a 52-week low of $0.75. The 50-Day Moving Average of the stock is 39.79%, while the 200-Day Moving Average is calculated to be 178.48%.
Shares Statistics:
According to the various share statistics, CMRX traded on average about 4.51M shares per day over the past 3-months and 1279250 shares per day over the past 10 days. A total of 89.94M shares are outstanding, with a floating share count of 79.66M. Insiders hold about 11.42% of the company’s shares, while institutions hold 41.80% stake in the company. Shares short for CMRX as of 1736899200 were 2154933 with a Short Ratio of 0.48, compared to 1734048000 on 3439284. Therefore, it implies a Short% of Shares Outstanding of 2154933 and a Short% of Float of 2.53.
